172 related articles for article (PubMed ID: 19766430)
1. In vivo selection of carbapenem-resistant Klebsiella pneumoniae by OmpK36 loss during meropenem treatment.
Song W; Suh B; Choi JY; Jeong SH; Jeon EH; Lee YK; Hong SG; Lee K
Diagn Microbiol Infect Dis; 2009 Dec; 65(4):447-9. PubMed ID: 19766430
[TBL] [Abstract][Full Text] [Related]
2. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
[TBL] [Abstract][Full Text] [Related]
3. Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.
Webster DP; Gaulton T; Woodford N; Pike R; Turton J; Perry C; Bowler IC
Int J Antimicrob Agents; 2010 Dec; 36(6):575-6. PubMed ID: 20869852
[No Abstract] [Full Text] [Related]
4. Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy.
Findlay J; Hamouda A; Dancer SJ; Amyes SG
Clin Microbiol Infect; 2012 Feb; 18(2):140-6. PubMed ID: 21745255
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
Sho T; Muratani T; Hamasuna R; Yakushiji H; Fujimoto N; Matsumoto T
Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
[TBL] [Abstract][Full Text] [Related]
6. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N
Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600
[TBL] [Abstract][Full Text] [Related]
7. In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase.
Cuzon G; Naas T; Guibert M; Nordmann P
Int J Antimicrob Agents; 2010 Mar; 35(3):265-8. PubMed ID: 20034767
[TBL] [Abstract][Full Text] [Related]
8. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Palasubramaniam S; Muniandy S; Navaratnam P
J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
[TBL] [Abstract][Full Text] [Related]
9. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
[TBL] [Abstract][Full Text] [Related]
10. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae.
Bidet P; Burghoffer B; Gautier V; Brahimi N; Mariani-Kurkdjian P; El-Ghoneimi A; Bingen E; Arlet G
Antimicrob Agents Chemother; 2005 Aug; 49(8):3562-5. PubMed ID: 16048985
[TBL] [Abstract][Full Text] [Related]
11. In vivo selection of OmpK35-deficient mutant after cefuroxime therapy for primary liver abscess caused by Klebsiella pneumoniae.
Lee CH; Chia JH; Chu C; Wu TL; Liu JW; Su LH
J Antimicrob Chemother; 2006 Oct; 58(4):857-60. PubMed ID: 16880175
[TBL] [Abstract][Full Text] [Related]
12. Imipenem-resistance in Klebsiella pneumoniae in Malaysia due to loss of OmpK36 outer membrane protein coupled with AmpC hyperproduction.
Palasubramaniam S; Karunakaran R; Gin GG; Muniandy S; Parasakthi N
Int J Infect Dis; 2007 Sep; 11(5):472-4. PubMed ID: 17337225
[No Abstract] [Full Text] [Related]
13. Meropenem-Vaborbactam Resistance Selection, Resistance Prevention, and Molecular Mechanisms in Mutants of KPC-Producing Klebsiella pneumoniae.
Sun D; Rubio-Aparicio D; Nelson K; Dudley MN; Lomovskaya O
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 29038260
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates.
Kim SY; Park YJ; Yu JK; Kim HS; Park YS; Yoon JB; Yoo JY; Lee K
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):85-91. PubMed ID: 16854555
[TBL] [Abstract][Full Text] [Related]
15. Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6.
Shigemoto N; Kuwahara R; Kayama S; Shimizu W; Onodera M; Yokozaki M; Hisatsune J; Kato F; Ohge H; Sugai M
Diagn Microbiol Infect Dis; 2012 Jan; 72(1):109-12. PubMed ID: 22078906
[TBL] [Abstract][Full Text] [Related]
16. Identification of IS1R and IS10R elements inserted into ompk36 porin gene of two multidrug-resistant Klebsiella pneumoniae hospital strains.
Lev AI; Astashkin EI; Shaikhutdinova RZ; Platonov ME; Kartsev NN; Volozhantsev NV; Ershova ON; Svetoch EA; Fursova NK
FEMS Microbiol Lett; 2017 May; 364(10):. PubMed ID: 28402509
[TBL] [Abstract][Full Text] [Related]
17. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573
[TBL] [Abstract][Full Text] [Related]
18.
Shields RK; Nguyen MH; Press EG; Chen L; Kreiswirth BN; Clancy CJ
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242667
[TBL] [Abstract][Full Text] [Related]
19. Reversion to susceptibility of a carbapenem-resistant clinical isolate of Klebsiella pneumoniae producing KPC-3.
Villa L; Capone A; Fortini D; Dolejska M; Rodríguez I; Taglietti F; De Paolis P; Petrosillo N; Carattoli A
J Antimicrob Chemother; 2013 Nov; 68(11):2482-6. PubMed ID: 23800906
[TBL] [Abstract][Full Text] [Related]
20. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
Conejo MC; Hernández JR; Pascual A
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
